Position
Chief Executive Officer
Company
Verastem Oncology
NeedhamBiotechnologyHealthcareHealth CareTherapeuticsBiopharmaDescription
Verastem Oncology has announced the appointment of Michael P. Bailey as President and Chief Executive Officer, effective January 1, 2027. This decision comes as part of a planned CEO transition following the retirement of Daniel Paterson.
Quick answer
Verastem Oncology Appoints Michael P. Bailey as Chief Executive Officer (October 14, 2026). Verastem Oncology is based in Needham, Massachusetts, United States.
- Who is the new Chief Executive Officer at Verastem Oncology?
- Verastem Oncology named Michael P. Bailey Chief Executive Officer, announced October 14, 2026.
- What did Verastem Oncology announce on October 14, 2026?
- Verastem Oncology has announced the appointment of Michael P. Bailey as President and Chief Executive Officer, effective January 1, 2027. This decision comes as part of a planned CEO transition following the retirement of Daniel Paterson.
- What does Verastem Oncology do?
- Verastem Oncology (Nasdaq: VSTM) is a late-stage development biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with RAS/MAPK...
- Where is Verastem Oncology based?
- Verastem Oncology is based in Needham, Massachusetts, United States.
- Which similar companies made leadership changes around the same time?
- Tempest Therapeutics (October 19, 2026), Gyre Therapeutics (October 22, 2026), Retension Pharmaceuticals (October 23, 2026) and Os Therapies (October 1, 2026) also announced leadership changes within 45 days of Verastem Oncology.
Source: Fundz verified event record.
Other recent leadership changes in Healthcare and Therapeutics
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Tempest Therapeutics Appoints John Frederick as Class III Director (October 19, 2026)
- Gyre Therapeutics Appoints Ying Luo as CEO and Thomas Eastling as CFO (October 22, 2026)
- Retension Pharmaceuticals Appoints Robert Wong as Chief Accounting Officer (October 23, 2026)
- OS Therapies Appoints Mr. Clem as Chief Commercial Officer and Mr. Knuettel as Chief Financial Officer (October 1, 2026)
- Richard J. Daly Appointed as Director of Aquestive Therapeutics (September 29, 2026)
- AbbVie Director Resigns Following CEO Appointment at Align Technology (November 2, 2026)
Who to call at Verastem Oncology, and when
A new leader at Verastem Oncology brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Verastem Oncology raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Verastem Oncology, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Verastem Oncology. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Verastem Oncology changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Verastem Oncology changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.